Sign in

CIK 0001516551

  • Non-accelerated filer
  • Smaller reporting company

Skye Bioscience, Inc.

Sign in to watch
Ticker
SKYE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
450692882
Phone
+1 858-410-0266
Business address
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
Former names
Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$613,506
in 6 filings

Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-02-24 Charych Deborah H. Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2025-02-24 Diep Tuan Tu Chief Development Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000
2025-02-24 Arora Puneet S. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +38,000 38,000
2024-11-18 ARSENAULT KAITLYN Chief Financial Officer Sale −43,026 $4.99 $215K 167,522
2024-11-18 Diep Tuan Tu Chief Development Officer Sale −19,489 $4.99 $97K 82,259
2024-11-18 ARSENAULT KAITLYN Chief Financial Officer Sale −43,206 $4.99 $216K 166,342
2024-11-18 DHILLON PUNIT Chief Executive Officer Sale −82,546 $4.99 $412K 329,823
2024-11-18 Grayson Paul A. Director Sale −86,244 $4.99 $430K 259,701
2024-11-15 ARSENAULT KAITLYN Chief Financial Officer Sale −190 $5.55 $1K 210,548
2024-11-15 Diep Tuan Tu Chief Development Officer Sale −85 $5.55 $472 101,748
2024-11-15 ARSENAULT KAITLYN Chief Financial Officer Sale −190 $5.55 $1K 209,548
2024-11-15 DHILLON PUNIT Chief Executive Officer Sale −364 $5.55 $2K 412,369
2024-11-15 Grayson Paul A. Director Sale −307 $5.55 $2K 345,945
2024-10-28 Diep Tuan Tu Chief Development Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2024-10-28 ARSENAULT KAITLYN Chief Financial Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2024-10-28 DHILLON PUNIT Chief Executive Officer Grant or award · Stock Option (Right to Buy) +650,000 650,000
2024-10-28 Schwab Andrew J. Director Grant or award · Stock Option (Right to Buy) +70,000 70,000
2024-10-28 Grayson Paul A. Director Grant or award · Stock Option (Right to Buy) +70,000 70,000
2024-10-28 Smith Karen L. Director Grant or award · Stock Option (Right to Buy) +70,000 70,000
2024-10-28 Charych Deborah H. Director Grant or award · Stock Option (Right to Buy) +70,000 70,000

Page 6 of 15 · 292 trades